# CXCR4 PET/MRI Targeted Imaging for Grading Diagnosis, Molecular Typing, and Prognostic Evaluation of Brain Glioma

> **NCT06234319** · — · UNKNOWN · sponsor: **Xiao Chen** · enrollment: 60 (estimated)

## Conditions studied

- Glioma

## Interventions

- **DIAGNOSTIC_TEST:** CXCR4

## Key facts

- **NCT ID:** NCT06234319
- **Lead sponsor:** Xiao Chen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02-15
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06234319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06234319, "CXCR4 PET/MRI Targeted Imaging for Grading Diagnosis, Molecular Typing, and Prognostic Evaluation of Brain Glioma". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06234319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*